Abaxis To Report Fourth Quarter And Fiscal Year 2013 Financial Results
Thursday, April 25, 2013
UNION CITY, Calif., April 17, 2013
UNION CITY, Calif., April 17, 2013 /PRNewswire/ --Abaxis, Inc. (NasdaqGS:
ABAX), a medical products company manufacturing point-of-care blood analysis
systems, has scheduled a conference call to discuss its financial results for
the fourth quarter and fiscal year 2013, ended March 31, 2013. The call will
be at 4:15 p.m. ET on Thursday, April 25, 2013. The Company will report
financial results for the fourth quarter and fiscal year 2013 after the market
closes on Thursday, April 25, 2013.
Participants can dial (877) 317-6789 or (412) 317-6789 to access the
conference call, or can listen via a live Internet web cast, which is
available in the Investor Relations section of the Company's website at
www.abaxis.com. A replay of the call is available by visiting www.abaxis.com
for the next 30 days or by calling (877) 344-7529 or (412) 317-0088,
confirmation code 10027780, through May 1, 2013.
Abaxis develops, manufactures, markets and sells portable blood analysis
systems for use in any veterinary or human patient-care setting to provide
clinicians with rapid blood constituent measurements. The system consists of
a compact, 5.1 kilogram (11.2 pounds), portable analyzer and a series of
single-use plastic discs, called reagent discs that contain all the chemicals
required to perform a panel of up to 13 tests on veterinary patients and 14
tests on human patients. The system can be operated with minimal training and
performs multiple routine tests on whole blood, serum or plasma samples. The
system provides test results in less than 12 minutes with the precision and
accuracy equivalent to a clinical laboratory analyzer. The veterinary
business also provides to the animal health and research market a line of
hematology instruments for point-of-care complete blood counts (CBC), a
specialty instrument to screen for and detect clotting disorders and to
measure equine fibrinogen levels, a handheld instrument for the rapid
assessment of certain critical care tests and rapid point-of-care tests for
Heartworm infections, Parvovirus, Giardia and Lyme disease. Abaxis, through
its AVRL division, provides routine laboratory testing as well as specialty
testing for veterinarians nationwide.
Contact: Clint Severson Lytham Partners, LLC
Chief Executive Officer Joe Dorame, Joe Diaz & Robert Blum
Abaxis, Inc. 602-889-9700
SOURCE Abaxis, Inc.
Press spacebar to pause and continue. Press esc to stop.